Haleon Plc - ADR [HLN] vs Neurocrine [NBIX] Detailed Stock Comparison
Haleon Plc - ADR
NYSE
Loading...
Neurocrine
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Haleon Plc - ADR wins in 7 metrics, Neurocrine wins in 12 metrics, with 0 ties. Neurocrine appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Haleon Plc - ADR | Neurocrine | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 19.93 | 41.02 | Haleon Plc - ADR |
| Price-to-Book Ratio | 5.08 | 5.03 | Neurocrine |
| Debt-to-Equity Ratio | 53.41 | 18.18 | Neurocrine |
| PEG Ratio | 21.36 | 0.58 | Neurocrine |
| EV/EBITDA | 33.86 | 25.47 | Neurocrine |
| Profit Margin (TTM) | 13.81% | 13.88% | Neurocrine |
| Operating Margin (TTM) | 22.21% | 21.18% | Haleon Plc - ADR |
| EBITDA Margin (TTM) | 22.21% | 21.18% | Haleon Plc - ADR |
| Return on Equity | 9.38% | 13.39% | Neurocrine |
| Return on Assets (TTM) | 4.61% | 8.67% | Neurocrine |
| Free Cash Flow (TTM) | $2.67B | $557.20M | Haleon Plc - ADR |
| Dividend Yield | 1.63% | N/A | N/A |
| 1-Year Return | -14.37% | 19.95% | Neurocrine |
| Price-to-Sales Ratio (TTM) | 3.63 | 5.48 | Haleon Plc - ADR |
| Enterprise Value | $119.46B | $13.44B | Haleon Plc - ADR |
| EV/Revenue Ratio | 8.07 | 5.35 | Neurocrine |
| Gross Profit Margin (TTM) | 55.38% | 98.36% | Neurocrine |
| Revenue per Share (TTM) | $2 | $25 | Neurocrine |
| Earnings per Share (Diluted) | $0.45 | $3.34 | Neurocrine |
| Beta (Stock Volatility) | 0.24 | 0.28 | Haleon Plc - ADR |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Haleon Plc - ADR vs Neurocrine Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Haleon Plc - ADR | -1.44% | 1.83% | -9.02% | -13.45% | -12.60% | -5.93% |
| Neurocrine | -0.19% | -2.95% | -3.65% | 5.67% | 26.25% | -0.81% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Haleon Plc - ADR | -14.37% | 45.81% | 19.84% | 19.84% | 19.84% | 19.84% |
| Neurocrine | 19.95% | 26.32% | 30.95% | 196.62% | 1,762.94% | 196.94% |
News Based Sentiment: Haleon Plc - ADR vs Neurocrine
Haleon Plc - ADR
News sentiment data is not available for Haleon Plc - ADR at this time.
Neurocrine
News based Sentiment: POSITIVE
Neurocrine Biosciences delivered a strong Q2 performance, exceeding revenue and EPS estimates, and presented positive Phase 2 data for osavampator. While insider selling is a concern, growing institutional investment and positive analyst coverage suggest continued optimism about the company's future prospects.
Performance & Financial Health Analysis: Haleon Plc - ADR vs Neurocrine
| Metric | HLN | NBIX |
|---|---|---|
| Market Information | ||
| Market Cap | $41.72B | $13.75B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 9,529,570 | 1,023,952 |
| 90 Day Avg. Volume | 8,844,817 | 832,457 |
| Last Close | $8.88 | $136.74 |
| 52 Week Range | $8.71 - $11.42 | $84.23 - $154.61 |
| % from 52W High | -22.24% | -11.56% |
| All-Time High | $11.42 (Jun 02, 2025) | $157.98 (Jul 29, 2024) |
| % from All-Time High | -22.24% | -13.44% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.17% |
| Quarterly Earnings Growth | 0.33% | 0.65% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.14% |
| Operating Margin (TTM) | 0.22% | 0.21% |
| Return on Equity (TTM) | 0.09% | 0.13% |
| Debt to Equity (MRQ) | 53.41 | 18.18 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.77 | $27.22 |
| Cash per Share (MRQ) | $0.08 | $9.84 |
| Operating Cash Flow (TTM) | $3.34B | $567.30M |
| Levered Free Cash Flow (TTM) | $2.58B | $367.04M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.63% | N/A |
| Last 12-Month Dividend | $0.17 | N/A |
Valuation & Enterprise Metrics Analysis: Haleon Plc - ADR vs Neurocrine
| Metric | HLN | NBIX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 19.93 | 41.02 |
| Forward P/E | 21.36 | 22.06 |
| PEG Ratio | 21.36 | 0.58 |
| Price to Sales (TTM) | 3.63 | 5.48 |
| Price to Book (MRQ) | 5.08 | 5.03 |
| Market Capitalization | ||
| Market Capitalization | $41.72B | $13.75B |
| Enterprise Value | $119.46B | $13.44B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.07 | 5.35 |
| Enterprise to EBITDA | 33.86 | 25.47 |
| Risk & Other Metrics | ||
| Beta | 0.24 | 0.28 |
| Book Value per Share (MRQ) | $1.77 | $27.22 |
Financial Statements Comparison: Haleon Plc - ADR vs Neurocrine
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HLN | NBIX |
|---|---|---|
| Revenue/Sales | $3.72B | $572.60M |
| Cost of Goods Sold | $1.66B | $9.20M |
| Gross Profit | $2.06B | $563.40M |
| Research & Development | $105.17M | $263.20M |
| Operating Income (EBIT) | $471.91M | $23.70M |
| EBITDA | $488.09M | $40.30M |
| Pre-Tax Income | $388.31M | $14.70M |
| Income Tax | $88.99M | $6.80M |
| Net Income (Profit) | $299.32M | $7.90M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HLN | NBIX |
|---|---|---|
| Cash & Equivalents | $911.46M | $194.10M |
| Total Current Assets | $5.59B | $1.64B |
| Total Current Liabilities | $6.42B | $522.90M |
| Long-Term Debt | $10.30B | $447.50M |
| Total Shareholders Equity | $21.57B | $2.54B |
| Retained Earnings | $36.76B | $-5.30M |
| Property, Plant & Equipment | $2.52B | $589.20M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HLN | NBIX |
|---|---|---|
| Operating Cash Flow | N/A | $21.80M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | $54.10M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-150.00M |
Short Interest & Institutional Ownership Analysis
| Metric | HLN | NBIX |
|---|---|---|
| Shares Short | 15.71M | 4.12M |
| Short Ratio | 1.93 | 5.71 |
| Short % of Float | 0.00% | 0.06% |
| Average Daily Volume (10 Day) | 9,529,570 | 1,023,952 |
| Average Daily Volume (90 Day) | 8,844,817 | 832,457 |
| Shares Outstanding | 12.25B | 99.40M |
| Float Shares | 8.99B | 98.01M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 0.13% | 1.02% |
Dividend Analysis & Yield Comparison: Haleon Plc - ADR vs Neurocrine
| Metric | HLN | NBIX |
|---|---|---|
| Last 12-Month Dividend | $0.17 | N/A |
| Last 12-Month Dividend Yield | 1.63% | N/A |
| 3-Year Avg Annual Dividend | $0.11 | N/A |
| 3-Year Avg Dividend Yield | 0.91% | N/A |
| 3-Year Total Dividends | $0.34 | N/A |
| Ex-Dividend Date | Apr 25, 2025 | N/A |